Skip to content

role of pippalyadi anuvasan basti compare with injection sclerotheropy for first and second degree hemorrhoid

Comparative study between Pippalyadi anuvasan and injection Sclerotherapy for first and second degree hemorrhoides

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029348
Enrollment
40
Registered
2020-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

Intervention1: pippalyadi anuvasan basti: 15 patients will be selected and treated with pippalyadi anuvasan basti and dose will be 40 ml in a day for 5 days and follow up on 7th and 15th day Control I

Sponsors

dr sachin girmaji pagde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient between the age group of 20 years to 60 years of age Patients will selected irrespective of sex religion occupation and socio economic status after clinical diagnosis of hemorrhoid 2) Patients associated with first and second degree hemorrhoid

Exclusion criteria

Exclusion criteria: 1) Hemorrhoid associated with fissure or fistula 2) Hemorrhoids secondary to systemic disease like chrons disease 3) Hemorrhoids secondary to systemic disease like ulcerative colitis 4) Patient with pregnancy diabetes mellitus hypertension chronic obstructive pulmonary disease ischemic heart disease 5) Patient suffering from bleeding disorder like prolonged bleeding time and cloting time

Design outcomes

Primary

MeasureTime frame
benificent of pippalyadi tail in hemorrhoidTimepoint: one week

Secondary

MeasureTime frame
to improve physiological condition to give safe cheap side effects free ayurvedic managementTimepoint: 15 days

Countries

India

Contacts

Public Contactdr sachin girmaji pagde

dr d y patil college of ayurved and research centre pimpri pune

pbjondhale@gmail.com8087072277

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026